Literature DB >> 32317266

KatG as Counterselection Marker for Nontuberculous Mycobacteria.

Aron Gagliardi1, Petra Selchow1, Sakshi Luthra1, Daniel Schäfle1, Bettina Schulthess1,2, Peter Sander3,2.   

Abstract

Keywords:  Mycobacterium abscessuszzm321990; isoniazid; nontuberculous mycobacteria

Mesh：

Substances：

Year:  2020        PMID： 32317266      PMCID： PMC7179591          DOI： 10.1128/AAC.02508-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  25 in total

1.  Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.

Authors:  Michelle H Larsen; Catherine Vilchèze; Laurent Kremer; Gurdyal S Besra; Linda Parsons; Max Salfinger; Leonid Heifets; Manzour H Hazbon; David Alland; James C Sacchettini; William R Jacobs
Journal:  Mol Microbiol       Date:  2002-10       Impact factor: 3.501

2.  Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth.

Authors:  Tawanda Gumbo; Arnold Louie; Weiguo Liu; Paul G Ambrose; Sujata M Bhavnani; David Brown; George L Drusano
Journal:  J Infect Dis       Date:  2006-12-07       Impact factor: 5.226

3.  Elucidation of Mycobacterium abscessus aminoglycoside and capreomycin resistance by targeted deletion of three putative resistance genes.

Authors:  Anna Rominski; Petra Selchow; Katja Becker; Juliane K Brülle; Michael Dal Molin; Peter Sander
Journal:  J Antimicrob Chemother       Date:  2017-08-01       Impact factor: 5.790

4.  Molecular Mechanisms of Intrinsic Streptomycin Resistance in Mycobacterium abscessus.

Authors:  Michael Dal Molin; Myriam Gut; Anna Rominski; Klara Haldimann; Katja Becker; Peter Sander
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

5.  Intrinsic rifamycin resistance of Mycobacterium abscessus is mediated by ADP-ribosyltransferase MAB_0591.

Authors:  Anna Rominski; Anna Roditscheff; Petra Selchow; Erik C Böttger; Peter Sander
Journal:  J Antimicrob Chemother       Date:  2016-12-20       Impact factor: 5.790

Review 6.  Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.

Authors:  Jakko van Ingen; Martin J Boeree; Dick van Soolingen; Johan W Mouton
Journal:  Drug Resist Updat       Date:  2012-04-21       Impact factor: 18.500

7.  inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.

Authors:  A Banerjee; E Dubnau; A Quemard; V Balasubramanian; K S Um; T Wilson; D Collins; G de Lisle; W R Jacobs
Journal:  Science       Date:  1994-01-14       Impact factor: 47.728

8.  The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.

Authors:  Y Zhang; B Heym; B Allen; D Young; S Cole
Journal:  Nature       Date:  1992-08-13       Impact factor: 49.962

9.  Access channel residues Ser315 and Asp137 in Mycobacterium tuberculosis catalase-peroxidase (KatG) control peroxidatic activation of the pro-drug isoniazid.

Authors:  Xiangbo Zhao; Hans-Petter Hersleth; Janan Zhu; K Kristoffer Andersson; Richard S Magliozzo
Journal:  Chem Commun (Camb)       Date:  2013-12-25       Impact factor: 6.222

10.  Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.

Authors:  Anna Rominski; Bettina Schulthess; Daniel M Müller; Peter M Keller; Peter Sander
Journal:  J Antimicrob Chemother       Date:  2017-11-01       Impact factor: 5.790
View more
  2 in total

1.  Apramycin Overcomes the Inherent Lack of Antimicrobial Bactericidal Activity in Mycobacterium abscessus.

Authors:  Petra Selchow; Diane J Ordway; Deepshikha Verma; Nicholas Whittel; Aline Petrig; Sven N Hobbie; Erik C Böttger; Peter Sander
Journal:  Antimicrob Agents Chemother       Date:  2021-12-20       Impact factor: 5.938

2.  Biological and Biochemical Evaluation of Isatin-Isoniazid Hybrids as Bactericidal Candidates against Mycobacterium tuberculosis.

Authors:  Matt D Johansen; Sumit Kumar; Clément Raynaud; Diana H Quan; Warwick J Britton; Philip M Hansbro; Vipan Kumar; Laurent Kremer
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.